- Home
- PTGX vs BSM Comparison
PTGX vs BSM Comparison
Compare PTGX & BSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- BSM
- Stock Information
- Founded
- PTGX 2006
- BSM 1876
- Country
- PTGX United States
- BSM United States
- Employees
- PTGX N/A
- BSM N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- BSM Oil & Gas Production
- Sector
- PTGX Health Care
- BSM Energy
- Exchange
- PTGX Nasdaq
- BSM Nasdaq
- Market Cap
- PTGX 2.8B
- BSM 3.1B
- IPO Year
- PTGX 2016
- BSM 2015
- Fundamental
- Price
- PTGX $42.97
- BSM $13.70
- Analyst Decision
- PTGX Strong Buy
- BSM Hold
- Analyst Count
- PTGX 8
- BSM 2
- Target Price
- PTGX $66.50
- BSM $15.00
- AVG Volume (30 Days)
- PTGX 990.2K
- BSM 324.4K
- Earning Date
- PTGX 05-06-2025
- BSM 05-05-2025
- Dividend Yield
- PTGX N/A
- BSM 10.96%
- EPS Growth
- PTGX N/A
- BSM N/A
- EPS
- PTGX 0.86
- BSM 0.92
- Revenue
- PTGX $207,801,000.00
- BSM $380,727,000.00
- Revenue This Year
- PTGX N/A
- BSM $14.57
- Revenue Next Year
- PTGX $7.13
- BSM $8.16
- P/E Ratio
- PTGX $50.68
- BSM $14.88
- Revenue Growth
- PTGX N/A
- BSM N/A
- 52 Week Low
- PTGX $24.22
- BSM $12.80
- 52 Week High
- PTGX $60.60
- BSM $16.48
- Technical
- Relative Strength Index (RSI)
- PTGX 43.08
- BSM 40.08
- Support Level
- PTGX $41.29
- BSM $13.45
- Resistance Level
- PTGX $46.12
- BSM $14.58
- Average True Range (ATR)
- PTGX 1.83
- BSM 0.27
- MACD
- PTGX -0.19
- BSM -0.06
- Stochastic Oscillator
- PTGX 27.81
- BSM 21.10
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About BSM Black Stone Minerals L.P. Common units representing limited partner interests
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests.